A proposal for new clinical concepts in the management of atrial fibrillation

Atrial fibrillation (AF) represents a growing public health burden. It is a complex condition, involving a number of etiologic factors and arrhythmia mechanisms associated with atrial remodeling. Greater understanding of these mechanisms may improve therapy. Current AF classification schemes are lim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2012-09, Vol.164 (3), p.292-302.e1
Hauptverfasser: Camm, A. John, MD, Al-Khatib, Sana M., MD, MHS, Calkins, Hugh, MD, Halperin, Jonathan L., MD, Kirchhof, Paulus, MD, Lip, Gregory Y.H., MD, Nattel, Stanley, MD, Ruskin, Jeremy, MD, Banerjee, Amitava, DPhil, Blendea, Dan, MD, Guasch, Eduard, MD, Needleman, Matthew, MD, Savelieva, Irina, MD, Viles-Gonzalez, Juan, MD, Williams, Eric S., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Atrial fibrillation (AF) represents a growing public health burden. It is a complex condition, involving a number of etiologic factors and arrhythmia mechanisms associated with atrial remodeling. Greater understanding of these mechanisms may improve therapy. Current AF classification schemes are limited by simplicity. A number of risk factors predict AF onset, and additional factors are being evaluated in registry studies. Doppler imaging and Holter monitoring in high-risk patients to predict the onset of AF and progression from paroxysmal to permanent AF are promising. There is a need for a novel multifactorial classification model encompassing AF duration, symptoms, markers of atrial remodeling, and a risk score for AF onset, persistence, progression, and complications to guide treatment and prognostication. Preventing AF onset with upstream therapy is of great interest, but current data are conflicting. More study is needed to optimize rhythm control with antiarrhythmic drugs and targeted ablation to specific patient populations at an earlier stage. There is little consensus on optimal rate control and no information relating to optimum rate control in specific populations. This article highlights new concepts in AF and directions for future research.
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2012.05.017